| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $8.51M | $6.28M | $7.49M | $17.65M | $32.88M |
| R&D | $4.87M | $2.98M | $3.57M | $12.99M | $27.22M |
| SG&A | $3.64M | $3.30M | $3.92M | $4.66M | $5.66M |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$10.31M | -$7.52M | -$6.91M | -$17.87M | -$32.47M |
| EPS (basic) | 2.3900 | 8.0800 | 2.5000 | 0.7100 | 1.3200 |
| EPS (diluted) | 2.3900 | 8.0800 | 2.5000 | – | – |
| Shares (diluted) | $4.31M | $930.82K | $2.77M | $25.14M | $24.60M |